We are live on ! Find out more
WRBC

W.R. Berkley Corp Portfolio holdings

AUM $1.86B
1-Year Est. Return 14.44%
This Fund
S&P 500
This Quarter Est. Return
-0.43%
1 Year Est. Return
+14.44%
3 Year Est. Return
+39.71%
5 Year Est. Return
+62.79%
10 Year Est. Return
+439.73%
AUM
$2.06B
AUM Growth
+$45.6M
Cap. Flow
+$87.3M
Cap. Flow %
4.23%
Top 10 Hldgs %
34.66%
Holding
573
New
20
Increased
144
Reduced
35
Closed
61
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTII
476
DELISTED
FutureTech II Acquisition Corp. Class A Common Stock
FTII
$251K 0.01%
25,000
CFFS
477
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
$250K 0.01%
24,999
ARGU
478
DELISTED
Argus Capital Corp. Class A Common Stock
ARGU
$249K 0.01%
24,278
-450
-2% -$4.51K
CREC
479
DELISTED
Crescera Capital Acquisition Corp Class A Ordinary Shares
CREC
$248K 0.01%
24,728
AONC
480
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$246K 0.01%
25,000
DNAD
481
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$246K 0.01%
25,000
CPAR
482
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$246K 0.01%
25,000
AISP
483
Airship AI Holdings
AISP
$71.3M
$245K 0.01%
24,727
LVRA
484
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
$245K 0.01%
24,728
LCAA
485
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
$243K 0.01%
24,561
WAVC
486
DELISTED
Waverley Capital Acquisition Corp. 1
WAVC
$242K 0.01%
24,726
MDH
487
DELISTED
MDH Acquisition Corp.
MDH
$242K 0.01%
24,562
FVIV
488
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
$242K 0.01%
24,560
MDAI icon
489
Spectral AI
MDAI
$55.7M
$238K 0.01%
24,115
DNAB
490
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$234K 0.01%
23,910
IPOD
491
CALL
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$206K 0.01%
+20,600
New +$206K
GLHA
492
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
$202K 0.01%
20,605
CDIO icon
493
Cardio Diagnostics
CDIO
$5.3M
$198K 0.01%
659
OBIO icon
494
Orchestra BioMed
OBIO
$254M
$197K 0.01%
19,902
-472,310
-96% -$4.68M
SHQA
495
DELISTED
Shelter Acquisition Corporation I Class A Common Stock
SHQA
$197K 0.01%
19,882
+100
+0.5% +$989
EBAC
496
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$195K 0.01%
19,650
OKLO
497
Oklo
OKLO
$8.42B
$194K 0.01%
19,782
FACA
498
DELISTED
Figure Acquisition Corp. I
FACA
$194K 0.01%
19,652
GTPA
499
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
$194K 0.01%
19,650
GTPB
500
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
$193K 0.01%
19,650

Similar funds

W.R. Berkley Corp's Q3 2022 Portfolio in Review

As of Q3 2022, W.R. Berkley Corp held 573 positions worth $2.06B, up 2.3% from $2.02B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

W.R. Berkley Corp deployed $87.3M of net new capital in Q3 2022, opening 20 new positions and adding to 144 existing holdings. Its largest new stake was Tekkorp Digital Acquisition Corp. Class A Ordinary Shares: 980,103 shares worth $9.82M.

By sector, the portfolio is most concentrated in Financials at 45% of assets, up from 43% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Cohn Robbins Holdings Corp., an estimated $8.16M trimmed.

  • W.R. Berkley Corp's largest Q3 2022 buy was Tekkorp Digital Acquisition Corp. Class A Ordinary Shares: 980,103 shares worth $9.82M.
  • W.R. Berkley Corp added most to Equitrans Midstream Corporation Common Stock in Q3 2022, an estimated $17M increase.
  • W.R. Berkley Corp's biggest Q3 2022 reduction was Cohn Robbins Holdings Corp., cutting an estimated $8.16M.
  • W.R. Berkley Corp fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $22.7M.
  • W.R. Berkley Corp's ten largest holdings make up 35% of its $2.06B portfolio in Q3 2022.
  • W.R. Berkley Corp opened 20 new positions and closed 61 in Q3 2022.
  • W.R. Berkley Corp's portfolio value rose 2.3% quarter-over-quarter to $2.06B.

Based on W.R. Berkley Corp's 13F filing for Q3 2022, filed 14 Nov 2022.